Cite
Sokolowska E, Kalaska B, Kaminski K, et al. The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin. Front Pharmacol. 2016;7:60doi: 10.3389/fphar.2016.00060.
Sokolowska, E., Kalaska, B., Kaminski, K., Lewandowska, A., Blazejczyk, A., Wietrzyk, J., Kasacka, I., Szczubialka, K., Pawlak, D., Nowakowska, M., & Mogielnicki, A. (2016). The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin. Frontiers in pharmacology, 760. https://doi.org/10.3389/fphar.2016.00060
Sokolowska, Emilia, et al. "The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin." Frontiers in pharmacology vol. 7 (2016): 60. doi: https://doi.org/10.3389/fphar.2016.00060
Sokolowska E, Kalaska B, Kaminski K, Lewandowska A, Blazejczyk A, Wietrzyk J, Kasacka I, Szczubialka K, Pawlak D, Nowakowska M, Mogielnicki A. The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin. Front Pharmacol. 2016 Mar 17;7:60. doi: 10.3389/fphar.2016.00060. eCollection 2016. PMID: 27014072; PMCID: PMC4794501.
Copy
Download .nbib